Research ArticleVIRAL INFECTIONS

A direct-acting antiviral drug abrogates viremia in Zika virus–infected rhesus macaques

See allHide authors and affiliations

Science Translational Medicine  10 Jun 2020:
Vol. 12, Issue 547, eaau9135
DOI: 10.1126/scitranslmed.aau9135

Article Information

vol. 12 no. 547

PubMed: 
Print ISSN: 
Online ISSN: 
History: 
  • Received for publication July 27, 2018
  • Accepted for publication March 20, 2020
  • .

Author Information

  1. So-Yon Lim1,
  2. Christa E. Osuna1,
  3. Katharine Best2,6,
  4. Ray Taylor3,
  5. Elsa Chen1,
  6. Gyeol Yoon1,
  7. Jessica L. Kublin1,
  8. Dane Schalk4,
  9. Nancy Schultz-Darken4,
  10. Saverio Capuano4,
  11. David Safronetz5,
  12. Ma Luo5,
  13. Steve MacLennan3,
  14. Amanda Mathis3,
  15. Yarlagadda S. Babu3,
  16. William P. Sheridan3,
  17. Alan S. Perelson6 and
  18. James B. Whitney1,7,*
  1. 1Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA.
  2. 2Merck Science Center, Cambridge, MA 02141, USA.
  3. 3BioCryst Pharmaceuticals, Birmingham, AL 35244, USA.
  4. 4Wisconsin National Primate Research Center, Madison, WI 53715, USA.
  5. 5National Microbiology Laboratory, 1015 Arlington Street, Winnipeg, R3E 3R2 Manitoba, Canada.
  6. 6Los Alamos National Laboratory, Los Alamos, NM 87545, USA.
  7. 7Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA 02139, USA.
  1. *Corresponding author. Email: jwhitne2{at}bidmc.harvard.edu

Altmetric

Article usage

Article usage: June 2020 to May 2021

AbstractFullPdf
Jun 20203830640204
Jul 20204054123
Aug 20201872417
Sep 20201762615
Oct 20201141211
Nov 2020138144
Dec 2020772411
Jan 20214134
Feb 2021621512
Mar 202154113
Apr 202152105
May 20212462

Stay Connected to Science Translational Medicine